WHO in talks with Russia on emergency use of Sputnik coronavirus vaccine

Published: Updated:

The World Health Organization (WHO) is in discussions with the Russian institute that developed the Sputnik V candidate vaccine against COVID-19 over its potential application for emergency use listing, the UN agency said on Thursday.

For more coronavirus news, visit our dedicated page.

In a statement to Reuters, the WHO said: “We look forward to receiving the data for their Sputnik V candidate vaccine. If a product submitted for assessment is found to meet the criteria for listing, WHO will publish the results widely.”

For all the latest headlines follow our Google News channel online or via the app

By granting the vaccine emergency use listing, the WHO would effectively be recommending its use to member states.

Russia’s Sputnik V vaccine is 92 percent effective at protecting people from COVID-19 according to interim trial results, the country’s sovereign wealth fund said on Wednesday.

Read more: After Pfizer’s vaccine announcement, Russia says it own vaccine over 90 pct effective

Top Content Trending